Biblio
Autologous Bone Marrow Mononuclear Cells Reduce Therapeutic Intensity for Severe Traumatic Brain Injury in Children. Pediatr Crit Care Med. 2015.
Clinical trials in traumatic brain injury: cellular therapy and outcome measures. Transfusion. 2019;59(S1):858-868.
. Correction: Human adipose-derived mesenchymal stem cells for acute and sub-acute TBI. PLoS One. 2021;16(12):e0261599.
. .
Human cord blood-derived regulatory T-cell therapy modulates the central and peripheral immune response after traumatic brain injury. Stem Cells Transl Med. 2020:e12706.
. . Innovations in cell therapy in pediatric diseases: a narrative review. Transl Pediatr. 2023;12(6):1239-1257.
. Strategies for CNS repair following TBI. Exp Neurol. 2015.
. .